Last Price Today's Change   Day's Range   Trading Volume
2.82   0.00 (0.00%)  0.00 - 0.00  0
Analyze this stock with MQ Trader system


Market Cap: 1,343 Million
NOSH: 476 Million
Avg Volume (4 weeks):43,594
4 Weeks Range:2.82 - 3.18
4 Weeks Price Volatility (%):
52 Weeks Range:2.82 - 3.81
52 Weeks Price Volatility (%):
Average Price Target: 2.85
Price Target Upside/Downside: +0.03
Stamp duty exempted for year 2021

Financial Highlight

Latest Quarter | Ann. Date 30-Jun-2021 [#2]  |  19-Aug-2021
Next QR | Est. Ann. Date: 30-Sep-2021  |  19-Nov-2021
T4Q P/E | EY: 25.18  |  3.97%
T4Q DY | Payout %: 1.87%  |  47.04%
T4Q NAPS | P/NAPS: 1.0042  |  2.81
T4Q NP Margin | ROE: 7.71%  |  11.15%


Date Subject
06-Sep-2021 【行家论股/视频】Apex保健 疫苗分销赚幅不高
06-Sep-2021 Apex Healthcare Berhad - First COVID-19 Vaccine Distribution
06-Sep-2021 Mplus Market Pulse - 6 Sept 2021
23-Aug-2021 Apex Healthcare - Gradual path to recovery
20-Aug-2021 Mplus Market Pulse - 20 Aug 2021
20-Aug-2021 Apex Healthcare - Slight recovery in associate company contributions
20-Aug-2021 Apex Healthcare Berhad - Slightly Below Expectations
09-Aug-2021 Healthcare - Positive recovery prospects but valuations demanding
22-Jun-2021 Daily technical highlights – (SAMCHEM, AHEALTH)
24-May-2021 Apex Healthcare - Looking towards recovery in FY22F
21-May-2021 PublicInvest Research Headlines - 21 May 2021
21-May-2021 Apex Healthcare Berhad - No Major Surprises
21-May-2021 Apex Healthcare - Weaker demand in 1QFY21
20-May-2021 Apex Healthcare - Earnings Slipped by 18% Qoq, Below Expectations
12-Mar-2021 Top 5 Malaysian stocks that have paid a growing dividend every year in the past 10 years - Shak Chee Hoi
01-Mar-2021 Apex Healthcare - All systems go
26-Feb-2021 PublicInvest Research Headlines - 26 Feb 2021
26-Feb-2021 Apex Healthcare - Prospects remain bright
26-Feb-2021 Apex Healthcare - Downgrading: Slower-than-expected Revenue Recovery
04-Feb-2021 Apex Healthcare - Orthopaedics for muscles of growth

Business Background

Apex Healthcare Bhd is a public limited liability company, incorporated and domiciled in Malaysia. The Company is an investment holding company for a group of companies engaged in the business of manufacturing, marketing, distributing and retailing of pharmaceuticals, diagnostics, orthopaedics and consumer healthcare products with direct operations in Malaysia, Singapore and Vietnam. Its operations are organized into three segments: Manufacturing and Marketing, Wholesale and Distribution, and Corporate.
Trade this stock for as low as 0.05% brokerage. Find out more.

  4 people like this.
NPRA1985 No significant change to reject budget at committee level: Dr M

FORMER Prime Minister (PM) Tun Dr Mahathir Mohamad said no significant change can be achieved if the proposed Budget 2021 is rejected at the committee level debate session.

“Rejecting the budget at the committee level, as it is said to be done, will not bring any significant impact on the government nor the proposed budget.

“It is just an attempt to divert the criticisms of the people who are disappointed with the attitude of the Opposition,” Dr Mahathir said in a statement today.

29/11/2020 9:36 PM
weijuin1992 Buy on rumours sell on fact ,it had come so far with rumours ,once confirm news will fly ,sit in if you believe in good company !
01/12/2020 12:08 PM
weijuin1992 Reversal to uptrend on small fraction of price yet big indicator to this share as it is not so volatile like the others , good chance striking up again !
01/12/2020 5:39 PM
NPRA1985 U.K. Approves Pfizer Coronavirus Vaccine, a First in the West
The emergency approval, ahead of the United States and the European Union, clears the way for Britain to begin mass inoculations. “Help is on its way,” one official said.

02/12/2020 6:36 PM
NPRA1985 Moderna Covid vaccine can get emergency authorisation approval in 2-3 days after panel meet: CEO

Moderna's vaccine candidate's full results from a late-stage study showed its vaccine was 94.1% effective with no serious safety concerns

03/12/2020 12:36 AM
NPRA1985 US says Covid-19 vaccines ready to be shipped nationwide immediately

03/12/2020 12:37 AM
NPRA1985 Janssen seeks Health Canada approval for its COVID-19 vaccine

03/12/2020 12:37 AM
NPRA1985 Johnson & Johnson has started a rolling submission with the European Medicines Agency (EMA) for its single-dose COVID-19 vaccine candidate.

03/12/2020 12:38 AM
NPRA1985 Promise of Covid vaccines is ‘phenomenal’, WHO says

03/12/2020 10:25 PM
NPRA1985 Equities up as Covid-19 cases drop, vaccine news spurs economic recovery bets

03/12/2020 10:47 PM
NPRA1985 DUBAI: Bahrain said on Friday it has granted emergency use authorization for the Pfizer/BioNTech COVID-19 vaccine, becoming the second country after Britain to approve it.

The kingdom had also approved Sinopharm’s COVID-19 vaccine in November for use by frontline workers.

05/12/2020 1:33 AM
NPRA1985 South Korea reaches deal to buy AstraZeneca's Covid-19 vaccine candidate

05/12/2020 1:46 AM
NPRA1985 500 million vaccine doses in Q1 2021 closer to reality, says WHO

05/12/2020 2:34 PM
NPRA1985 UAE says Sinopharm vaccine has 86% efficacy against COVID-19

DUBAI (Reuters) - An experimental coronavirus vaccine developed by China’s Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.

The Gulf Arab state in July started Phase 3 clinical trials of the vaccine, developed by Beijing Institute of Biological Product, a unit of Sinopharm’s China National Biotec Group (CNBG). In September, the UAE approved its emergency use for certain groups.

The analysis also shows “99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease”, the ministry said in a statement carried by the state news agency.

“The analysis shows no serious safety concerns,” it said.

It also said it had officially registered the vaccine, without elaborating, and that 31,000 volunteers across 125 nationalities participated in the UAE trial.

09/12/2020 3:12 PM
NPRA1985 United Arab Emirates Claims China’s Sinopharm Vaccine Is 100% Effective At Preventing Moderate And Severe Covid-19

TOPLINE The experimental vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective at preventing Covid-19 infection and 100% effective at preventing severe and moderate disease, health officials from the United Arab Emirates announced Wednesday, although with scarce detail provided about the trial.

The UAE health ministry cited an interim analysis of a late-stage clinical trial involving 31,000 volunteers as the source of its information, though neither they nor Sinopharm provided any data from the trial to validate the claims such as how many participants were infected or how many actually received the vaccine.

The ministry said “no serious safety concerns” were observed, though, again, no information on side effects was provided.

The ministry said the announcement is a “significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.”

The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it says could eventually lead to the shot’s widespread authorization.

09/12/2020 10:25 PM
NPRA1985 Hong Kong’s Ming Pao daily said in its editorial that there were grounds to believe that the UAE must have been stringent with the review and registration of the Chinese vaccine, given the country’s record of being transparent in its anti-virus policymaking and mass testing.

“The UAE also maintains sound ties with the West so sourcing vaccines from the United States or elsewhere should not be a grave challenge. If the Chinese vaccine is not safe or effective, there is no reason for the UAE to endorse Beijing’s vaccine propaganda and risk its own image and the health of its own people.

“Thus the UAE’s approval and its top leader’s injection of the SinoPharm vaccine have come as a much-needed vote of confidence that will help convince more countries. Diversified supply of vaccines, with viable alternatives from China, is key to ensuring fair and equitable access by poor countries,” said the op-ed.

SinoPharm revealed that senior officials in Egypt and Bahrain also took part in trials held there.

10/12/2020 11:55 PM
NPRA1985 FDA intends to 'proceed towards an authorization' of Covid-19 vaccine, official says, as cases soar

(CNN)The FDA has informed Pfizer it intends "to proceed towards an authorization" of the manufacturer's Covid-19 vaccine, the US Health and Human Services Secretary told ABC on Friday morning, as the country is deep into a worsening health crisis.

The statement comes a day after an FDA panel recommended the agency grant an emergency use authorization for the Pfizer-BioNTech coronavirus vaccine.Other key steps remain, but if those hurdles are cleared, the first vaccinations in the US could happen early next week, HHS Secretary Alex Azar told ABC's George Stephanopoulos.

"The FDA informed Pfizer that they do intend to proceed toward an authorization for their vaccine," Azar told ABC Friday morning.

12/12/2020 2:26 AM
NPRA1985 Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

12/12/2020 3:04 PM
NPRA1985 Bursa Malaysia is expected to trend higher next week



Bursa Malaysia expected to break 1,700 psychological level

Bursa Malaysia is expected to trend higher next week, with the key FTSE Bursa Malaysia KLCI (FBM KLCI) breaking the psychological level of 1,700, and poised to march into the new year with a big bang.

12/12/2020 6:05 PM
FT1981 this counter not active?
07/01/2021 11:19 AM
FT1981 https://app.sinchew.com.my/content/content_2406317.html?type=detail&fileId=2406317&colID=6660
07/01/2021 11:20 AM
NPRA1985 Post removed. Why?
03/02/2021 10:03 PM
KaiHong this is a stable stock
15/02/2021 3:00 PM
Aa01182 Sleeping giant
11/03/2021 11:02 PM
jomvalueinvest2 Vaccine counter wave coming ? Kanger seems like more hot now
18/05/2021 2:39 PM
Mr.Sm Invest123 Apex Healthcare Bhd
Target price: RM3.33 BUY

AMINVESTMENT BANK RESEARCH (MAY 24): The drag from associated company Straits Apex Sdn Bhd (SA) is expected to ease in the coming quarters. Major customer Smith and Nephew Sales Sdn Bhd, which contributes to about 62% of SA sales, performed the bulk of 1QFY21’s transactions in 4QFY20. Pandemic uncertainty has also led it to delay the bulk of its remaining orders to 2HFY21. Currently, order levels are similar to last year’s.

However, poor utilisation rates at SPP NOVO are expected to keep manufacturing segment margins depressed; therefore, the group is deferring expansion plans until pharmaceutical demand returns.

Meanwhile, rising freight and raw material costs are likely to compress margins in the coming quarters. While ASPs for group brand products remain unchanged, they may rise in the coming quarters. External products have already seen a 6% increase in ASP.

With the Ministry of Health’s (MoH) expenses tied up by the pandemic’s resurgence, the group believes government tenders are hard to come by at the moment. We expect this to normalise in FY22F, as the bulk of the MoH’s mass vaccinations will have already been completed by then. Going forward, we remain positive on Apex’s future prospects as a recovery play.
07/06/2021 6:49 PM
wallstreetrookie A Guide to Investing in Healthcare Companies

Low tier: IHH, TopGlove, Supermaxm Pharmaniaga
High tier: YSPSAH, Apex Healthcare, Duopharma
10/06/2021 3:03 PM
wallstreetrookie Though the company only gets a small slice of the meat within the pharmaceutical business, manufacturing generic medication remains profitable and attractive for defensive investments.
22/06/2021 4:55 AM
wallstreetrookie I like this company
24/06/2021 6:20 AM
wallstreetrookie Political instability always presents the best opportunities to buy the dips. When everyone's attention is grabbed by glove companies, it is the perfect chance to buy in alternative healthcare and pharmaceutical companies. And for what's worth, Apex Healthcare is a well-managed company
24/06/2021 1:02 PM
wallstreetrookie If you want defensive stocks, this is the one
24/06/2021 11:32 PM
CynicalCyan 21 years ago, AHEALTH was first listed on the Second Board with around 100 mil in market capitalisation.
21 years later, AHEALTH became one of the most consistent profitable companies on Bursa Main Market with about 1 bil in market capitalisation.

Hats off to such an outstanding Malaysian company. May the next 21 years be even better.
26/06/2021 10:29 PM
telurgoreng Apex and YSP are both good defensive counters. But YSP seems to be the better value given the price and dividend yield.
15/07/2021 4:19 PM
15/07/2021 4:21 PM
telurgoreng They are investing a lot into production, machine and factories hence less money to be given out as dividends. The share is non-speculative due to most of the holdings are held by the directors and owners. Hence it is very hard to goreng shares like this. These are the "Tanker" shares, they can easily tank recession and outlast the smallcap counters.

If you prefer gambling and speculative shares, you're better off buying penny stocks as those have almost 0 returns and price swing wildly due to rumours and speculation. Depending on which type of investor you are, some people prefer insurance and banking, some people prefer healthcare, some prefer energy, some people just follow the wind and hype according to what come out in the newspaper during the moment.. Price movement may be boring, but this is for slow and steady, keep for long term or retirement kind like bank shares.

My take is, the share hasn't seen any bonus in over 10 years. They have grown steadily in terms of asset. Hence, I foresee they may issue bonus eventually when the industry recovers and we are in better financial situation. It's not like they're having debt problems or not-profitable. The share price is just boring cause most of the shareholding held by the owners and directors, so there is not enough public shares for operators to goreng.
15/07/2021 10:47 PM
Nepo Apex declared bonus issues in Year 2018
16/07/2021 6:08 AM
Hafid I rather wait until below rm1.40
17/07/2021 5:21 AM
Bgt 9963 Post removed. Why?
17/07/2021 9:04 AM
trum Steady
21/08/2021 10:20 AM
wallstreetrookie Company has been forgotten
27/08/2021 10:50 AM
wallstreetrookie Read @telurgoreng's post. It is good research and I've taken note of it
27/08/2021 10:50 AM
wallstreetrookie Another stock to watch next week
29/08/2021 11:31 PM
investortrader88 BURSA MALAYSIA TRADE STATISTICS - 27 AUG 2021

Participation / Status / Nett RM ( M )

Institutions Nett sellers - 239.8

Retail Nett sellers - 16.9

Foreign Nett buyers + 256.7

Source: theSundaily - Business
30/08/2021 7:21 PM
investortrader88 https://simplywall.st/stocks/my/pharmaceuticals-biotech/klse-ahealth/apex-healthcare-berhad-shares/news/heres-what-we-like-about-apex-healthcare-berhads-klseahealth
30/08/2021 7:22 PM
investortrader88 https://www.thestar.com.my/business/business-news/2021/08/30/foreign-buying-on-bursa-surges-to-rm96433mil-last-week
30/08/2021 7:27 PM
investortrader88 Top 25 shareholders own 84.79% of Apex Healthcare Berhad's

Apex Pharmacy Holdings Sdn. Bhd.

Washington H. Soul Pattinson and Company Limited

Md Md Dewal

Public Mutual Berhad

Lim Teh Realty Sdn Berhad

Kirk Kee

Yoon Yee Liew

Xepa Holdings Sendirian Berhad

Yan Meng Tan

DBS Group Holdings Limited, Asset Management Arm

Apex Holdings (Pte) Ltd.

Employees Provident Fund of Malaysia

Heng Koon Chan

Choon Neo Teoh

Singam Kumarasamy


Lee Hee Yeo

Manulife Asset Management Services Berhad

Capital Dynamics Asset Management Sdn Bhd

Siew Heong Oh

Yee Hui Wong

Jin Thai Tan

Ding Susy

Leong Kuen

Kenanga Investors Berhad
30/08/2021 10:32 PM
wallstreetrookie best alternative healthcare
01/09/2021 3:13 PM
Nepo 3 Sept 2021

Apex Healthcare Bhd said it has inked an agreement with Innova Bio-Medical Pte Ltd to supply the Sinopharm Covid-19 vaccine to private healthcare practitioners in Singapore. Innova is part of the Innova Medical Group, a global company specializing in innovative screening, testing and diagnostics for cancer, heart disease, arterial calcification, stroke, and virus detection focused on infectious diseases. Under the deal, Innova will supply the Chinese-made vaccine to Apex’s wholly-owned unit in Singapore, Apex Pharma Marketing Pte Ltd, for onward sale and distribution to hospitals and private clinics within the city state, said Apex Healthcare.
04/09/2021 11:34 AM
Nepo (吉隆坡3日讯)Apex保健(AHEALTH,7090,主板消费股)在新加坡的独资子公司 ——Apex Pharma Marketing(APM)获得国药(Sinopharm)疫苗供应合约。



04/09/2021 11:36 AM
wallstreetrookie @Nepo that is bad news
13/09/2021 9:59 AM


1. 顶级手套业绩逊色 目标价砍至1.68令吉 星洲日報/投資致富‧企業故事
2. 云顶双雄满手“烂牌” 林国泰如何吃糊? 星洲日報/投資致富‧企業故事
3. JointVenture of Aimflex & Huawei !! Undiscovered Automation counter Gem in Bursa? Darkhorse Discover
4. What happened to Evergrande and its impacts to the steel industry Shiba Capital
5. Top Glove Corporation Berhad - Missing Expectations PublicInvest Research
6. 【行家论股/视频】顶级手套 财测目标价下调 南洋行家论股
7. The Legend of the Chinese Mooncake - Koon Yew Yin Koon Yew Yin's Blog
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View candlestick stock charts with Technical indicators
MQ Affiliate
Be rewarded by being an MQ Affiliate

117  185  455  1519 

Top 10 Active Counters
 TIGER-OR 0.0050.00 
 TANCO 0.245+0.005 
 SERBADK 0.35-0.015 
 PASUKGB 0.08+0.005 
 BINTAI 0.62+0.05 
 KAB 0.39+0.015 
 AIMFLEX 0.17+0.005 
 FINTEC 0.020.00 
 NWP 0.2250.00 
 DNEX 0.76-0.005